Comprehensive genomic profiling of lung cancer using a validated panel to explore therapeutic targets in East Asian patients.

2 Given the increasing availability of various targeted therapies, combined with the maturity of new technologies, comprehensive genomic profiling (CGP) of lung cancer is rapidly becoming an important trend in cancer pathology diagnosis. 3 , 4 , 5 , 6 Comprehensive information regarding tumor‐specific molecular abnormalities is valuable in choosing suitable treatment options to maximize therapeutic benefitsand minimize therapy‐associated risks. 7 , 8 , 9 Moreover, comprehensive analysis of mutations i

also in 1,052 other papers